DP

Dusan Perovic

Partner at Two Sigma Ventures

New York, New York

Overview 

Dusan Perovic is a Partner at Two Sigma Ventures in New York, with a background in investment banking, asset management, and corporate development. He has successfully invested in companies like Gameto (Series B) and Hexagon Bio (Series B), showcasing a strong track record in venture capital and alternative investments.

Work Experience 

  • Partner

    2016 - Current

Two Sigma Ventures is an early-stage venture capital fund that invests in companies run by highly driven people.

  • Board Member

    2022

Freeform is a 3D printing company offering metal 3D printing solutions for manufacturing companies.

Raised $59,000,000.00 from NVentures, AE Industrial Partners, Two Sigma Ventures, Threshold, Founders Fund and 10x Founders.

  • Board Observer

    2021

Exai Bio is an orphan non-coding RNAs and AI-based liquid biopsy company.

Raised $67,500,000.00 from Section 32, Casdin Capital and Two Sigma Ventures.

  • Board Member

    2020

Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.

Raised $96,000,000.00 from Bristol-Myers Squibb, Alexandria Venture Investments, Lux Capital, Evotec, Dolby Family Ventures, Two Sigma Ventures and The Column Group.

  • Board Member

    2020

Isabl develops cancer diagnostic tests based on whole genome and RNA sequencing data.

Raised $5,000,000.00 from National Cancer Institute.

  • Board Observer

    2020

Hexagon Bio is a data-driven biotech company developing targeted small molecule therapeutics.

Raised $193,600,001.00 from Two Sigma Ventures, The Column Group, Nextech Invest, 8VC, CPP Investments and ATEL Growth Capital.

  • Board Member

    2019

Terray Therapeutics is a biotechnology company that transforms small molecule drug discovery.

Raised $200,000,000.00 from What If Ventures, Digitalis Ventures, NVentures, Goldcrest Capital, XTX Ventures, Alexandria Venture Investments, Madrona, Maverick Capital, Two Sigma Ventures and Bedford Ridge Capital.

  • Investor

    2018

Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery.

Raised $643,000,000.00 from Alexandria Venture Investments, BlackRock, HOF Capital, CPP Investments, Google Ventures, Foresite Capital, Casdin Capital, Temasek Holdings, T. Rowe Price and Third Rock Ventures.

  • Investor

    2017

Kallyope uses the science of gut-brain biology to create medicines that transform human health.

Raised $487,200,000.00 from Bill & Melinda Gates Foundation.

  • Partner, Two Sigma Ventures

    2014

  • VP, Research and Data Engineering

    2012 - 2015

  • Associate and VP, Business Development

    2007 - 2012

Two Sigma Impact is focused on workforce impact where we anticipate innovative and thoughtful investments in humans.

Articles About Dusan

Relevant Websites